Liver antioxidant and aerobic status improves after metformin and melatonin administration in a rat model of high-fat diet and mammary carcinogenesis.

Abstract

Oxidative stress is involved in the development of various cancers. In the present study, the effect of long-term administration of peroral antidiabetic metformin and pineal hormone melatonin on liver antioxidant and aerobic status in female Sprague-Dawley rats carrying mammary tumors induced by N-methyl-N-nitrosourea was evaluated. Both substances were administered in a preventive and curative manner (12 days before and 16 weeks after the carcinogen application). Carcinogen administration induced oxidative stress: the level of thiobarbituric acid reactive substances (TBARS) considered as a marker of reactive oxygen species (ROS) generation in liver increased as well as the level of oxidatively modified protein content (OMP; aldehyde and ketone derivates). Metformin administration restored succinate dehydrogenase and lactate dehydrogenase activity and associated ROS production and OMP content to the level of intact rats, with predominant activation of superoxide dismutase (SOD) and glutathione reductase (GR). Melatonin alone and in combination with metformin also decreased TBARS content. OMP content decreased in all groups receiving chemoprevention. The rise in total antioxidant capacity after melatonin and particularly metformin and melatonin combination might result from the initiation of anaerobic metabolism and increasing SOD, GR, and glutathione peroxidase activity. Long-term administration of metformin and melatonin exerts antioxidant properties in liver, especially in combination.

• Authors: Natalia Kurhaluk, Bianka Bojková, Pawel J Winklewski
• Journal: Canadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 96 Issue 8 Pg. 790-797 (Aug 2018) ISSN: 1205-7541 [Electronic] Canada
• PMID: 29658305 (Publication Type: Journal Article)

Chemical References

• Antioxidants
• Triglycerides
• Metformin
• L-Lactate Dehydrogenase
• Succinate Dehydrogenase
• Aspartate Aminotransferases
• Alanine Transaminase
• Melatonin

Topics

• Aerobiosis
• Alanine Transaminase (metabolism)
• Animals
• Antioxidants (metabolism)
• Aspartate Aminotransferases (metabolism)
• Carcinogenesis (drug effects, pathology)
• Diet, High-Fat
• Female
• L-Lactate Dehydrogenase (metabolism)
• Lipid Peroxidation (drug effects)
• Liver (enzymology, metabolism, pathology)
• Male
• Mammary Neoplasms, Animal (blood, drug therapy, pathology)
• Melatonin (administration & dosage, pharmacology, therapeutic use)
• Metformin (administration & dosage, pharmacology, therapeutic use)
• Oxidation-Reduction
• Rats, Sprague-Dawley
• Succinate Dehydrogenase (metabolism)
• Triglycerides (blood)